I am delighted to share that parts of our long-running Tumor Profiler study were published in Nature Medicine! Specifically, this paper provides a clinical utility analysis of the melanoma (skin cancer) subcohort, with the analysis led by the team of Andreas Wicki at the University Hospital Zurich.
We find that multi-omic molecular and functional profiling of tumors from patients with melanoma was feasible, returning data within four weeks and informing treatment recommendations in 75% of cases.
For more information, check out the news item at the ETH Zurich and the Tumor Profiler website.